
Schrödinger - Physics-based Software Platform for Molecular …
Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotechnology, and materials research.
Maestro - Schrödinger
Complete modeling environment for your molecular discovery Discover better quality molecules, faster Maestro is Schrödinger’s streamlined portal for access to state-of-the-art predictive …
About us - Schrödinger
Our mission is to improve human health and quality of life by transforming the way therapeutics and materials are discovered.
Schrödinger, Inc. - Financials - SEC Filings
Investor FAQs Information Request Form IR Contact Send us an email at [email protected] Investor Email Alerts To opt-in for investor email alerts, please enter your email address in the …
Pipeline of Collaborative & Proprietary Drug Discovery Programs ...
We are leveraging our computational platform and massive computing power to advance our proprietary programs both independently and in collaboration with leading biotech and …
Schrödinger - 分子の発見と設計のための物理ベースのソフトウェ …
Dec 17, 2025 · 難溶性薬物の放出メカニズムを解明する – ASD研究の新たなアプローチ | Modelling amorphous solid dispersion (ASD) release mechanisms OCT 15, 2025 | AbbVie と …
Introduction to molecular modeling in drug discovery
Work hands-on with Schrodinger’s Maestro and LiveDesign on your own schedule whenever convenient for you within the course session Jump start your research program by learning …
Schrödinger Announces CFO Appointment - ir.schrodinger.com
May 20, 2025 · Founded in 1990, Schrödinger has over 800 employees operating from 15 locations globally. To learn more, visit www.schrodinger.com, follow us on LinkedIn and …
Modeling for Catalysis & Reactivity | Schrödinger Materials Science
Accelerate catalyst design and optimize chemical reactions at the atomic level The need for new materials is urgent, driven by growing market demands and stringent environmental …
Our Team - Schrödinger
Schrödinger’s collaborative leadership team is committed to achieving the best possible outcomes for our customers, partners, patients, and other stakeholders.